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Necrotizing enterocolitis (NEC) afflicts approximately
10% of extremely preterm infants with high fatality.
Inappropriate bacterial colonization with Enterobac-
teriaceae is implicated, but no specific pathogen has
been identified. We identify uropathogenic E. coli
(UPEC) colonization as a significant risk factor for
the development of NEC and subsequent mortality.
We describe a large-scale deep shotgun metage-
nomic sequence analysis of the early intestinal mi-
crobiome of 144 preterm and 22 term infants. Using
a pan-genomic approach to functionally subtype
the E. coli, we identify genes associated with NEC
and mortality that indicate colonization by UPEC.
Metagenomic multilocus sequence typing analysis
further defined NEC-associated strains as sequence
types often associated with urinary tract infections,
including ST69, ST73, ST95, ST127, ST131, and
ST144. Although other factors associated with pre-
maturity may also contribute, this report suggests a
link between UPEC and NEC and indicates that
further attention to these sequence types as poten-
tial causal agents is needed.
INTRODUCTION
Necrotizing enterocolitis (NEC) is a leading cause of morbidity
and mortality in preterm infants. One in fourteen infants born
prior to 32 weeks of gestation develop NEC, and nearly one-third
of cases is fatal (Neu and Walker, 2011). The etiology of NEC is
not confidently established but appears to result from a hyperin-
flammatory response to the gut microbiota (Nanthakumar et al.,
2011; Neu and Walker, 2011). For years, research on NEC
focused on identifying pathogens responsible for triggering
NEC onset (Boccia et al., 2001; Hoy et al., 2000). With the advent
of high-throughput sequencing, the focus shifted toward identi-2912 Cell Reports 14, 2912–2924, March 29, 2016 ª2016 The Authorfying microbial community dysbiosis that predisposes infants to
develop NEC (Claud et al., 2013; La Rosa et al., 2014; Mai et al.,
2011; Morrow et al., 2013; Torrazza and Neu, 2013; Wang et al.,
2009; Zhou et al., 2015).
Relative to term infants, the enterocytes of preterm infants
exhibit excessive toll-like receptor 4 (TLR4) signaling in response
to lipopolysaccharide (LPS)-bearing organisms (Nanthakumar
et al., 2011). Themost abundant LPS-bearing bacteria in the pre-
term infant are of the phylum Proteobacteria, family Enterobac-
teriaceae. Some have reported that Proteobacteria are more
abundant at the time of NEC onset (Wang et al., 2009), whereas
others have reported a surge in Proteobacteria a week or more
prior to NEC onset (Claud et al., 2013; Morrow et al., 2013; Tor-
razza and Neu, 2013; Zhou et al., 2015). These reports support
the view that an excessive quantity or increase in Proteobacteria
triggers a hyperinflammatory response that leads to NEC. How-
ever, many preterm infants are highly colonized by Proteobacte-
ria and experience a surge in this phylum without developing
NEC (La Rosa et al., 2014). Thus, a generalized Proteobacteria
dysbiosis alone does not adequately explain this disease.
NEC often occurs in outbreaks (Boccia et al., 2001; Mein-
zen-Derr et al., 2009), and investigations using culture-based
techniques have reported that Enterobacteriaceae members
Escherichia coli, Klebsiella pneumoniae, and Enterobacter
cloacae were most often associated with NEC (Boccia et al.,
2001; Hoy et al., 2000). The most recent investigations of
NEC have used culture-independent 16S rDNA community
profiling (Claud et al., 2013; La Rosa et al., 2014; Mai et al.,
2011; Morrow et al., 2013; Torrazza and Neu, 2013; Wang et
al., 2009 Zhou et al., 2015), which lacks the ability to resolve
strains with ‘‘pathogenic potential’’ from non-pathogenic mem-
bers of a lineage. A recent shotgun metagenomic study with
five temporally clustered cases of NEC and five healthy infants
provided strain-level resolution but did not find a specific,
‘‘genetically distinct’’ pathogenic strain associated with the
case cluster (Raveh-Sadka et al., 2015), and cultivation of
Enterobacteriaceae strains associated with 15 episodes of sus-
pected NEC (eight confirmed) reached a similar conclusion
(Hoy et al., 2000).s
Table 1. Characteristics of 144 Preterm and 22 Term Study
Infants
Characteristic
NEC
Cases
Preterm
Control
Term
Control
Infants, number 27 117 22
Infant birth weight,
median (range), grams*
850
(415,1340)
904
(520,1741)
3476
(2217,4173)
Infant gestational age,
median (range), weeks*
26 (23,28) 26 (23, 29) 39 (38, 41)
Male, number (%) 15 (56%) 61 (52%) 11 (50%)
Cesarean section delivery,
number (%)
16 (59%) 70 (60%) 10 (45%)
Multiple births, number (%)*** 2 (7%) 49 (42%) 2 (9%)
Primiparous, number (%)** 15 (56%) 28 (24%) 7 (32%)
Days infant antibiotic
use in first 14 days of life,
median (range), days*
7 (0, 14) 3 (0, 14) 0 (0, 0)
Human milkR 75%
feedings over the first
month of lifea, number (%)
17 (63%) 86 (74%)
Maternal antibiotics at
delivery (%)*
12 (44%) 79 (68%) –
Infant with sample available
for days 3-9, number (%)
8 (50%) 67 (75%) 22 (100%)
Infant with sample available
for days 10-16, number (%)
15 (94%) 81 (91%) 18 (82%)
Infant with sample available
for days 17-22, number (%)
7 (44%) 37 (42%) 7 (32%)
*p < 0.05, **p = 0.002, ***p = 0.001
aHuman milk feeding calculated as the number of days of feedings since
birth to the occurrence of NEC, death, or the end of the first month of life,
whichever occurred first.We analyzed deep shotgun metagenomic sequencing of fecal
samples collected from 144 preterm infants in 3 neonatal inten-
sive care units and 22 term infants.We applied an assembly-free,
pangenome-based computational analysis to determine the
E. coli-specific gene content of strains within the infant micro-
biomes. Accessory genes involved in iron acquisition, phospho-
transferase systems (PTSs), and D-serine metabolism were
characteristic of strains associated with NEC risk. Additional
analysis characterized the risk strains as uropathogenic E. coli
(UPEC) (Flores-Mireles et al., 2015; Wiles et al., 2008; Zhang
and Foxman, 2003). We present evidence that (i) colonization
by UPEC is a risk factor for development of NEC and (ii) UPEC
correlated with death as an outcome. These findings suggest
an association between UPEC and NEC and provide a founda-
tion for advancing the epidemiology of NEC.
RESULTS
Subjects and Overview
We generated metagenomic shotgun sequence data from 144
preterm infants less than 30 weeks gestational age (GA) and 22
term infants greater than 37 weeks GA with stool samples
collected between days 3 to 22 of life (Tables 1 and S1; Figures
S1 and S2). We divided the collection period into three windowsCell(days 3–9, 10–16, and 17–22) and selected the latest postnatal
sample per infant per window for inclusion in community anal-
ysis. NEC cases and controls had a similar average day of life
of sample collection within each of the three windows analyzed.
We investigated the prevalent Enterobacteriaceae species in
relation to risk of NEC. These results led us to functionally sub-
type E. coli and associate UPEC with NEC and infant death.
Infant Microbiome at Days 3–9 Postpartum
Samples from 97 infants, 75 preterm and 22 term, were collected
days 3–9 postpartum (median day of sample collection = 7). 8 of
the preterm infants later developed NEC. MetaPhlAn (v2.0) (Se-
gata et al., 2012; Truong et al., 2015) was applied in order to
determine the relative abundance of species present (Figure 1A
and Table S1). Defining carriage to be when a sample contains
a species present at a minimum of 1% relative abundance, we
determined the most commonly carried species in this sampling
window. In descending order, Enterococcus faecalis occurred
in 33 of 75 preterm infants (a prevalence of 44%) followed by
Staphylococcus epidermidis (43%), Streptococcus sp. GMD4S
(37%), Klebsiella spp. (25%), E. coli (24%), Serratia marcescens
(21%),Enterobacter aerogenes (12%), andEnterobacter cloacae
(12%) (Figure 2, red circles).
In many samples, a single species dominated the community.
We calculated the median relative abundance (MRA, scaled in
the [0.0–1.0] interval) of the most commonly carried species,
excluding samples in which the species were not carried. The
most abundant species, ordered by MRA, were E. coli (0.92),
S. marcescens (0.24), Klebsiella spp. (0.14), Streptococcus sp.
GMD4S (0.12), and E. faecalis (0.11) (Figure 2).
Term infant samples were more diverse than preterm infant
samples, as assessed with Shannon’s index (SI) (Figure S3A;
SI = 1.59 ± 0.95 and 1.1 ± 0.77, respectively; p = 0.015). To iden-
tify taxa that were significantly enriched in either term or preterm
infants, we used LEfSe (Segata et al., 2011) (Figures S4A–S4C).
Taxa enriched in term infant samples included the phyla Acti-
nobacteria (e.g., Bifidobacterium species) and Bacteroidetes,
as well as some of the Firmicutes, including the classes Clostri-
dia, Erysipelotrichia, and Negativicutes (e.g., Veillonella). In
contrast, taxa enriched in preterm infant samples included Firmi-
cutes classes Bacilli (e.g., S. epidermidis) and Lactobacillales
(e.g., E. faecalis) as well as the Gammaproteobacteria genus
Enterobacter.
In preterm infants, early empirical antibiotic prophylaxis con-
sisted of ampicillin and gentamicin. The number of days of anti-
biotic treatment during the first 14 days of life was used to stratify
infants. We observed few, if any, significant differences in micro-
biome composition between preterm infants with no postnatal
antibiotic treatment and infants with only a few days of treatment
(data not shown). Thus, we compared preterm infants who
received 0–6 days treatment (low) to those who received
7–14 days treatment (high) during the first 2 weeks of life (Figures
1A, S3, and S4D–S4E). Diversity did not differ significantly
comparing low and high antibiotic treatment (SI = 1.06 ± 0.79
and 1.18 ± 0.7, respectively; p = 0.582). Infants who received
low treatment were enriched in the class Bacilli; high treatment
infants were enriched in the genus Bacteroides (Figures S4D
and S4E). These differences may be due to antibiotic treatment,Reports 14, 2912–2924, March 29, 2016 ª2016 The Authors 2913
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Figure 1. Species Composition and Relative Abundance in the Infant Gut
(A) Days 3–9 postpartum.
(B) Days 10–16 postpartum.
(C) Days 17–22 postparum.
Species are ranked top to bottom by average relative abundance across samples. Species presented exhibit a minimum average relative abundance of 0.2% or
achieve at least 5% relative abundance in at least one sample (complete abundance data in Table S1). Samples were hierarchically clustered with Bray-Curtis
dissimilarity. Color indicates relative abundance on a logarithmic scale.or, alternatively, infants with these profiles may differ in their like-
lihood of treatment with antibiotics.
There were 46 Cesarean births and 29 vaginal births in the pre-
term infants with days 3–9 samples. Diversity did not differ signif-
icantly by delivery mode (SI = 1.21 ± 0.81 versus 1.02 ± 0.73; p =
0.305). However, Bacilli were enriched inCesareanbirths (Figures
S4FandS4G). Preterm infantswhodevelopedNEChadsimilar di-
versity in comparison to preterm controls (SI = 1.11 ± 0.79 versus
0.96± 0.56; p= 0.597), and therewere nonotable differentially en-
riched taxa between these groups (data not shown).
Infant Microbiome at Days 10–16 Postpartum
Infant sampleswere collected during days 10–16 from96preterm
and 18 term infants (median day of sample collection = 13);
15 preterm infants later developed NEC. (Figure 1B, Table S1).2914 Cell Reports 14, 2912–2924, March 29, 2016 ª2016 The AuthorThe prevalence of the most commonly carried organisms was
S. epidermidis (46%), E. faecalis (45%), Klebsiella spp. (36%),
E. cloacae (26%), E. coli (24%), and K. oxytoca (21%) (Figure 2).
However, the species with the highest MRA were E. coli (0.93),
S. marcescens (0.39), V. parvula (0.33), Klebsiella spp. (0.19),
K. oxytoca (0.11), andStreptococcus sp.GMD4S (0.12) (Figure 2).
Again, term infant samples weremore diverse than preterm in-
fant samples (SI = 1.82 ± 01.1 versus 1.13 ± 0.76; p = 0.002). Pre-
term infants delivered vaginally tended to have lower diversity
than Cesarean births (SI = 0.96 ± 0.68 versus 1.25 ± 0.79; p =
0.061), and infants with high antibiotic treatment tended to
have lower diversity than those with low antibiotic exposure
(SI = 0.92 ± 0.81 versus 1.22 ± 0.71; p = 0.073). However, infants
who developed NEC did not significantly differ in diversity from
preterm controls (SI = 1.01 ± 0.92 versus 1.15 ± 0.72; p = 0.524).s
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Figure 2. Relative Abundance and Prevalence of the Most Frequently Occurring Species in the Early Preterm Infant Microbiome
Fourteen of the most prevalent species observed in the preterm infant microbiome are presented. E.coli is an outlier with a median relative abundance exceeding
0.80 in each of the three collection windows presented. Relative abundance calculations include only samples where the infant carried the organism with at least
1% relative abundance. Prevalence is indicated as red circle, mean relative abundance as a blue diamond, and median relative abundance as box and whisker
plot.Term infants were enriched in nearly all taxa, except that
the species S. epidermidis, E. faecalis, E. cloacum, and
S. marcescens were all enriched in preterm infants in this sec-
ond collection window (Figures S5A and S5B). Differences in
delivery mode or antibiotic treatment indicated few differ-
ences in these samples (Figures S5C and S5D). Strepto-
coccus and the order Bacteroidales were enriched in infants
with high antibiotic exposure (Figures S5C and S5D). Citro-
bacter and Klebsiella were enriched in Cesarean delivered
infants (Figures S5E and S5F). NEC infants did not exhibit
notable, differentially enriched taxa relative to preterm con-
trols (data not shown).CellInfant Microbiome at Days 17–22 Postpartum
44 preterm infants and 7 term infants were included in the days
17–22 collection window (median day of sample collection =
20); 7 preterm infants later developed NEC (Figure 1C; Table
S1). The most prevalent organisms were E. faecalis (52%), Kleb-
siella spp. (39%), E. coli (36%), E. cloacae (25%), C. perfringens
(20%), C. difficile (18%), K. oxytoca (18%), V. parvula (18%),
C. freundii (16%), S. epidermidis (16%), and V. atypica (14%).
Again, the species with the highest MRA provided a different
picture—E. coli (0.81), Klebsiella spp, (0.48), V. atypica (0.21),
E. cloacae (0.14), C. freundii (0.13), and Streptococcus sp.
GMD4S (0.12) (Figure 2).Reports 14, 2912–2924, March 29, 2016 ª2016 The Authors 2915
Term infant samples were againmore diverse than the preterm
infant samples (SI = 2.35 ± 1.2 versus 1.24 ± 0.69; p = 0.0017).
Similar to the days 10–16 samples, diversity did not differ by de-
livery mode (SI = 1.11 ± 0.67 versus 1.35 ± 0.67; p = 0.253). How-
ever, infants with high antibiotic treatment were markedly less
diverse (SI = 0.91 ± 0.67 versus 1.39 ± 0.64; p = 0.032). Samples
from infants who developed NEC tended to be less diverse than
preterm controls, but the difference was not significant (SI = 0.87
± 0.63 versus 1.32 ± 0.68; p = 0.122).
Term infants were enriched in nearly all taxa except E. faecalis
and Streptococcus, which were enriched in preterm infants (Fig-
ures S6A and S6B). Delivery mode indicated few differences,
although E. aerogenes was enriched in Cesarean births (Fig-
ure S6C). Infants with high antibiotic treatment were specifically
enriched in E. coli relative to low treatment infants who were en-
riched in the order Clostridiales, genus Veillonella, and Klebsiella
spp. (Figures S6D and S6E). Finally, infants who developed NEC
had less Veillonella and were specifically enriched in E. coli (Fig-
ures S6F and S6G).
E. coli and NEC-Associated Death
Of 27 infants who developed NEC, 13 had E. coli at greater than
1% relative abundance in at least one sample collected from
days 3–22 of life; 10 of the 13 infants died. The next most abun-
dant species, carried in 12 infants (4 deaths), wasKlebsiella spp.;
2 NEC cases carried both E. coli and Klebsiella spp. In infants
who developedNEC,Klebsiella spp. carriage in at least one sam-
ple correlated with NEC survival (p = 0.057), whereas E. coli car-
riage correlated with death (p = 0.054).
Defining E. coli Sub-types as a Risk Factor for NEC
Considering the prior association of Enterobacteriaceae with
NEC, and our observations that E. coli was associated with
NEC and NEC-associated death, we hypothesized that strain
level differences among colonizing E. coli may further stratify
NEC risk. To test this hypothesis, we developed assembly-
free, metagenomic approaches to subtype E. coli by gene con-
tent (Scholz et al., 2016) and by multilocus sequence type
(MLST) assignment (Figure 3, Tables 2, 3, S1, and S2). Both ap-
proaches indicated that the dominant E. coli strain-type in any
single infant was constant over the collection period. Infant
21461 was an exception, providing two samples with each pre-
senting a different dominant strain type. For association analysis,
we considered genes that could be assigned to a KEGG Orthol-
ogy (KO) group (Table S2) (Kanehisa et al., 2014). The UniProt
Knowledgebase (http://www.uniprot.org/uniprot/) was used to
infer E. coli-specific gene assignments from KO assignments.
919 of 3,004 total genes with KO assignments were considered
accessory genes in that they were not found in all infant samples
(Table S2). Strain-specific gene presence and absence profiles
were used to hierarchically cluster the samples (Figure 3). Infants
who developed NEC were observed throughout the large cluster
(clade 1) and in a second smaller cluster (clade 2).
E. coli Accessory Genes Associated with NEC-
Containing Clades
In total, 120 genes significantly associated with clade 1 and
clade 2, and 152 genes associated with clade 3 (p < 0.02) (Tables2916 Cell Reports 14, 2912–2924, March 29, 2016 ª2016 The Author2, 3, and S2). Because strains from infants that developed NEC
tightly co-clustered with strains from infants who did not develop
NEC (Figure 3)—and, thus, would have very similar gene con-
tent—we did not expect, and did not find, any E. coli genes
significantly associated with development of NEC (data not
shown). Genes involved in phenylalanine metabolism and the
degradation of aromatic compounds (Dı´az et al., 2001) were
associated with clade 3. Phylogroup A strains exhibit capacity
for aromatic acid utilization, whereas clinical isolates generally
lack these capacities (Burlingame and Chapman, 1983). Func-
tional gene categories significantly associated with clades 1
and 2 included iron acquisition and metabolism, D-serine detox-
ification and metabolism, and sugar-specific PTSs. These gene
categories are found to be enriched in UPEC strains, where
they most likely represent adaptation to the environment of the
urinary tract (Brzuszkiewicz et al., 2006; Chen et al., 2006; Lloyd
et al., 2007). Thus, we speculated that clade 1 and 2 E. coli
strains may be functionally related to UPEC. The observed clade
structure (Figure 3) also indicated E. coli subtypes within the
three clades we defined. We sought to further resolve these sub-
types so as to better define the E. coli lineages present in our
cohort.
Metagenomic MLST Analysis Indicates that Clade 1 and
2 Strains Are UPEC
We were able to assign an existing an multilocus sequence type
(MLST) (Maiden et al., 1998) to most samples with at least 1%
relative abundance of E. coli (Figure 3; Table S1). The assigned
MLSTs are remarkable in their concordance with the clade struc-
ture obtained independently from accessory gene content—all
MLSTs mapped to discreet subclades within our functionally
defined clusters. Phylogroup B2 MLSTs 73, 95, 127, 131, 144,
and 998 fall in clade 1. Clade 2 represents MLST 69 and is a phy-
logroup D type. Clade 3 contains representatives that have been
recognized in animal hosts—MLSTs 648 and 2200 have been
placed in phylogroup D (Ciccozzi et al., 2013; Giufre` et al.,
2012; Wieler et al., 2011)—as well as phylogroup A strains.
The dataset contains five fraternal twin pairs (Figure 3, consec-
utively numbered, shaded infant IDs). The four preterm pairs
each share the same MLST assignment, whereas the term pair
differs. Preterm infant 12511 developed NEC and died, whereas
the sibling twin, infant 12512, survived free from NEC.
We identified one potential strain turnover event in a single in-
fant. E. coli from infant 21461 typed as ST127 in a sample from
day 7 and as ST144 from a day 10 sample. Infant 21461 devel-
oped NEC and died on day 33. Both samples indicated greater
than 95% relative abundance of E. coli. Each sample clustered
by functional composition with other samples of the same
MLST. In the association analyses presented, we have included
the ST127 sample.
UPEC as a NEC Pathogen and Risk Factor for Death
We identified UPEC MLSTs belonging to phylogroups B2 and D
as associated with NEC risk. We then calculated the ORs
regarding UPEC as a risk factor for NEC, NEC-associated
deaths, and all deaths. In our primary analysis, we included
143 of the available 144 preterm infants less than 30 weeks GA
(Table 4; Figure S2). The data from one preterm infant whos
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Figure 3. Functional and Metagenomic MLST Sub-typing of E. coli Strains Present in Metagenomic Samples Indicates UPEC Lineages Are
Associated with NEC Risk
E. coli accessory gene-content information (Table S2) was used to hierarchically cluster infant strains and indicated three distinct functional clades. Approxi-
mately Unbiased (AU) p value, a multiscale bootstrap resampling method (Shimodaira, 2004), indicates the strength of support for clusters. Clades 1 (red) and
2 (green) contain NEC cases. Metagenomically identified MLST IDs are indicated, and the corresponding phylogroup inferred from literature and available re-
sources (http://mlst.warwick.ac.uk/mlst/). Consecutively numbered and shaded infant IDs indicate fraternal twin pairs. Boxed infant IDs indicate two strains of
E.coli identified in temporally separated samples from a single infant (patient ID 21461).survived free from NEC or death (12611) failed in E. coli analysis,
allowing no conclusions about UPEC status for this infant to be
made; thus, this infant was excluded from analysis. We defined
controls as preterm infants who survived hospitalization free of
NEC. The analysis included 27 NEC cases and 21 deaths (of
which 15 deaths were NEC-associated and 6 were independent
of NEC). UPEC was significantly associated with NEC, NEC-
associated deaths, all deaths, and NEC or death, with unad-
justed ORs of 4.1 (p = 0.003), 10.3 (p < 0.001), 5.7 (p < 0.001),
and 3.4 (p < 0.007), respectively.
We then modeled NEC and death outcomes in relation to
UPEC, adjusting for potential confounders using logistic regres-
sion analysis; NEC-associated deaths and death free of NEC
were not modeled separately because of a lack of adequate
case numbers. All factors included in Table 1 were evaluated
as potential confounding factors for NEC. Potential confounding
factors were examined univariately in relation to NEC; only those
factors identified as significant at p < 0.10 were considered in lo-Cellgistic regression models. From this process, six clinical factors
were identified as potential confounding factors for NEC: birth
weight, GA at birth, singleton versus multiple birth, primiparity
versus multiparity, lack of antibiotic use by the mother at the
time of delivery, and infant exposure to antibiotics in postnatal
life. Given themodest number of NEC cases, we aimed to further
reduce the number of confounding factors to be included in
models of NEC outcomes. Infant GA and birth weight were highly
correlated (rho = 0.7, p < 0.001), and thus, only one of these fac-
tors was included in given regression models. Antibiotic use of
mother and infant were examined jointly in relation to NEC; the
most significant prediction of NEC was found with lack of
maternal perinatal antibiotics at delivery combined with high in-
fant antibiotic use (R7 days in the first two weeks of life), and this
variable was used for modeling. Five covariates were entered
into the logistic model: high-risk antibiotic use, infant GA (weeks)
or infant birth weight (grams), multiparity, multiple birth, and car-
riage of UPEC. Stepwise removal of factors that were notReports 14, 2912–2924, March 29, 2016 ª2016 The Authors 2917
Table 2. Selected Genes Associated with Clade 3
KOa pb Gene Description
Catabolism of 4-hydroxyphenylacetic acid
K02508 1.4E-02 hpaA; 4-hydroxyphenylacetate
3-monooxygenase operon regulatory
protein
K00483 3.6E-04 hpaB; 4-hydroxyphenylacetate
3-monooxygenase
K00484 3.6E-04 hpaC; flavin reductase (NADH)
K00455 3.6E-04 hpaD; 3,4-dihydroxyphenylacetate
2,3-dioxygenase
K00151 3.6E-04 hpaE; 5-carboxymethyl-2-
hydroxymuconic-semialdehyde
dehydrogenase
K01826 3.6E-04 hpaF; 5-carboxymethyl-2-
hydroxymuconate isomerase
K05921 3.6E-04 hpaG; 4-hydroxyphenylacetate
degradation bifunctional isomerase/
decarboxylase
K02509 3.6E-04 hpaH; 2-oxo-hept-3-ene-1,7-dioate
hydratase
K02510 3.6E-04 hpaI; 4-hydroxy-2-oxoheptanedioate
aldolase
K02511 1.4E-02 hpaX; 4-hydroxyphenylacetate
permease
Aerobic catabolism of phenylacetic acid
K00146 8.2E-05 feaB; phenylacetaldehyde
dehydrogenase
K02609 5.2E-03 paaA; ring-1,2-phenylacetyl-CoA
epoxidase subunit
K02610 8.2E-05 paaB; ring-1,2-phenylacetyl-CoA
epoxidase subunit
K02611 8.2E-05 paaC; ring-1,2-phenylacetyl-CoA
epoxidase subunit
K02612 8.2E-05 paaD; ring-1,2-phenylacetyl-CoA
epoxidase subunit
K02613 8.2E-05 paaE; ring-1,2-phenylacetyl-CoA
epoxidase subunit
K01692 8.2E-05 paaF; enoyl-CoA
hydratase
K15866 8.2E-05 paaG; 2-(1,2-epoxy-1,2-dihydrophenyl)
acetyl-CoA isomerase
K02614 8.2E-05 paaI; acyl-CoA thioesterase
K02615 8.2E-05 paaJ; acetyl-CoA acetyltransferase
K01912 8.2E-05 paaK; phenylacetate-CoA ligase
K02616 8.2E-05 paaX; phenylacetic acid degradation
operon negative regulatory protein
K02617 2.9E-08 paaY; phenylacetic acid degradation
protein
K02618 8.2E-05 paaZ; oxepin-CoA hydrolase / 3-oxo-5,
6-dehydrosuberyl-CoA semialdehyde
dehydrogenase
K00276 8.2E-05 tynA; primary-amine
oxidase
Table 2. Continued
KOa pb Gene Description
Phenylpropanoate/cinnamate degradation
K05711 1.5E-06 hcaB; 2,3-dihydroxy-2,3-
dihydrophenylpropionate dehydrogenase
K05710 1.5E-06 hcaC; 3-phenylpropionate/trans-cinnamate
dioxygenase ferredoxin subunit
K00529 1.5E-06 hcaD; 3-phenylpropionate/trans-cinnamate
dioxygenase ferredoxin reductase subunit
K05708 1.5E-06 hcaE; 3-phenylpropionate/trans-cinnamate
dioxygenase alpha subunit
K05709 3.3E-05 hcaF; 3-phenylpropionate/trans-cinnamate
dioxygenase beta subunit
K05817 1.5E-06 hcaR; hca operon transcriptional activator
K05712 6.0E-04 mhpA; 3-(3-hydroxy-phenyl)propionate
hydroxylase
K05713 6.0E-04 mhpB; 2,3-dihydroxyphenylpropionate 1,2-
dioxygenase
K05714 6.0E-04 mhpC; 2-hydroxy-6-ketonona-2,4-
dienedioic acid hydrolase
K02554 6.0E-04 mhpD; 2-keto-4-pentenoate hydratase
K01666 6.0E-04 mhpE; 4-hydroxy 2-oxovalerate aldolase
K04073 6.0E-04 mhpF; acetaldehyde dehydrogenase
homology to the hydrogenase hyc operon
K12136 1.5E-06 hyfA; hydrogenase-4 component A
K12137 1.5E-06 hyfB; hydrogenase-4 component B
K12138 1.5E-06 hyfC; hydrogenase-4 component C
K12139 1.5E-06 hyfD; hydrogenase-4 component D
K12140 1.5E-06 hyfE; hydrogenase-4 component E
K12141 1.5E-06 hyfF; hydrogenase-4 component F
K12143 3.3E-05 hyfF; hydrogenase-4 component H
K12142 1.5E-06 hyfG; hydrogenase-4 component G
K12144 1.5E-06 hyfI; hydrogenase-4 component I
K12145 1.5E-06 hyfJ; hydrogenase-4 component J
K12146 1.5E-06 hyfR; hydrogenase-4 transcriptional
activator
aKEGG orthology (KO) identifier
bp is calculated as two-tailed Fisher’s exact probability. A complete gene
list with p values is found in Table S2.
2918 Cell Reports 14, 2912–2924, March 29, 2016 ª2016 The Authorsignificant at p < 0.10 resulted in amodel that included only high-
risk antibiotic use (p < 0.001), multiple birth (p = 0.002), and car-
riage of UPEC (p = 0.001). In order to ensure adequate control for
immaturity, infant GA was re-entered into the model and kept,
as its presence decreased the adjusted OR for UPEC by 13%.
In the final logistic model for NEC, the adjusted OR for carriage
of UPEC was 6.0 (95% CI 2.0, 18.1; p = 0.002), which remained
higher than the OR (Table 4) without adjustment for covariates.
The logistic model for NEC or death included the same co-vari-
ates and had a somewhat lower OR than for NEC alone (4.6, 95%
CI 1.6, 13.0, p = 0.004), but the adjusted OR was again higher
than the crude OR. 12 infants developed NEC by the last day
of sample availability, day 22 (early), and 15 infants developed
NEC after day 22 (late). We analyzed the association between
identification of UPEC and odds of NEC that occurred earlys
Table 3. Selected Genes Associated with NEC Risk Clades 1 and 2
KOa pb Gene Description
Clade 1 associated
K10125 2.1E-12 dctB; (C4-dicarboxylate transport) two-component system histidine kinase
K10126 2.1E-12 dctD; (C4-dicarboxylate transport) two-component system response regulator
K01451 2.1E-12 hipO; hippurate hydrolase
K00016 2.1E-12 L-lactate dehydrogenase
K02765 2.1E-12 PTS system, Fused glucose-specific IIB component
Clade 1 and 2 associated
K08094 7.3E-10 hxlB; 6-phospho-3-hexuloisomerase
K03445 7.4E-04 nepI; MFS transporter, DHA1 family, purine ribonucleoside efflux pump
Iron acquisition
K16087 8.2E-05 chuA: outer membrane heme/hemoglobin/transferrin/lactoferrin receptor protein
K07225 8.2E-05 chuS: putative hemin transport protein
K07227 8.2E-05 chuX Putative heme iron utilization protein
K06202 1.6E-03 CyaY protein
K15721 1.9E-02 fyuA; pesticin/yersiniabactin receptor
K04786 5.2E-03 irp1; yersiniabactin nonribosomal peptide/polyketide synthase
K04784 1.9E-02 irp2; yersiniabactin nonribosomal peptide synthetase
K05374 1.9E-02 irp4: ybtT; yersiniabactin synthetase, thioesterase component
K04783 1.9E-02 irp5; yersiniabactin salicyl-AMP ligase
K04781 1.9E-02 irp9; salicylate synthetase
K07230 3.0E-04 putative iron transporter
K11607 4.5E-04 sitB; manganese/iron transport system ATP-binding protein
K11605 4.5E-04 sitC; manganese/iron transport system permease protein
K11606 5.1E-05 sitD; manganese/iron transport system permease protein
K05372 5.2E-03 ybtA; AraC family transcriptional regulator
Phosphotransferase systems
K02538 1.4E-02 manR; activator of the mannose operon, transcriptional antiterminator
K02768 1.4E-02 PTS system, fructose-specific IIA component
K02769 1.4E-02 PTS system, fructose-specific IIB component
K02765 1.5E-06 PTS system, Fused glucose-specific IIB component
K02812 8.2E-05 sorF; PTS system, sorbose-specific IIA component
K02813 7.1E-04 sorB; PTS system, sorbose-specific IIB component
K02814 7.1E-04 sorA; PTS system, sorbose-specific IIC component
K02815 7.1E-04 sorD; PTS system, sorbose-specific IID component
K11189 7.1E-04 fryA; PTS-HPR; phosphocarrier protein
Serine
K01753 1.6E-03 dsdA; D-serine dehydratase
K13636 1.8E-02 dsdC; LysR family transcriptional regulator, D-serine deaminase activator
K13629 3.5E-02 dsdX; D-serine transporter
aKEGG Orthology (KO) identifier
bp is calculated as two-tailed Fisher’s exact probability. A complete gene list with p values is found in Table S2.(versus all controls) and odds of NEC that occurred late (versus
all controls). The association between NEC and carriage of
UPECwas not significantly influenced by the timing of NEC onset
(OR early NEC = 3.7 [1.06, 12.8], p = 0.041; OR late NEC = 4.5
[1.5, 13.9], p = 0.009). Nevertheless, the slightly lower OR for
early NEC compared to late NEC is potentially consistent with
previous data suggesting that the timing of NEC onset might
have somewhat different microbial risk profile (Morrow et al.,
2013; Zhou et al., 2015). Thus, the finding that UPEC carriageCellassociated with NEC and death outcomes is highly significant
does not appear to be due to confounding factors.
DISCUSSION
Recent studies have correlated increased relative abundance
of Enterobacteriaceae with NEC and suggest this represents a
dysbiosis predisposing preterm infants to NEC (Claud et al.,
2013; Morrow et al., 2013; Torrazza and Neu, 2013). EpidemicReports 14, 2912–2924, March 29, 2016 ª2016 The Authors 2919
Table 4. Carriage of UPEC and Odds of NEC and Death Outcomes
Outcomes No. UPEC/Cases (%) Unadjusted OR (95% CI), p value Adjusted OR (95% CI), p value
NEC 12/27 (44.4) 4.1 (1.5, 11.2) 0.003 6.0 (2.0, 18.1) 0.002
NEC-associated deaths 10/15 (66.7) 10.3 (2.8, 42.2) <0.001 –
All deaths 11/21 (52.4) 5.7 (1.8, 17.2) <0.001 –
NEC or death 13/33 (39.4) 3.4 (1.3, 8.6) 0.007 4.6 (1.6, 13.0) 0.004
Controlsa 18/111 (16.2) 1.0 1.0
Adjusted OR calculated from logistic regression models including UPEC carriage, multiple birth, maternal and infant antibiotic use, and infant gesta-
tional age.
aControls were defined as preterm infants who survived free of NEC.outbreaks have also been documented, suggesting the involve-
ment of infectious agents (Boccia et al., 2001). Culture-based
studies have most frequently implicated E. coli and Klebsiella
spp. (Boccia et al., 2001; Hoy et al., 2000) and, to a lesser extent,
clostridial species, especially C. butyricum (Boccia et al., 2001;
Cassir et al., 2015). In our patient population, we identify carriage
of uropathogenic subtypes of E. coli as a significant contributor
to risk of NEC.
Uropathogenic E. coli Is a Risk Factor for NEC and NEC-
Associated Death
The major translational findings from this work are that (i) coloni-
zation by UPEC is a highly significant risk factor for development
of NEC and (ii) UPEC is even more strongly correlated with mor-
tality as an outcome. In our study, 44% of the 27 NEC cases (OR
4.1, p = 0.003) and 52% of the 21 deaths (OR 5.7, p < 0.001)
could be attributed to UPEC in comparison to 16% of the 111
controls whowereNEC-free survivors. Of the three free-standing
NICUs in our study, located in two different cities, each had two
or more UPEC-associated cases of NEC. Thus, our findings
imply that some proportion of NEC and death cases in other sites
may occur as the result of colonization by UPEC strains.
Early Strain Identification May Reduce NEC Risk
Using assembly-free, metagenomic approaches, we identified
E. coli-specific accessory gene content that functionally distin-
guished clades associated with NEC-risk. Furthermore, metage-
nomic MLST assignment showed that NEC risk is associated
with several important pathogenic MLSTs. Both lines of evi-
dence implicate UPEC. Colonization by UPEC lineages is not
restricted to preterm infants; we found that term infants were
also colonized by similar MLST as preterm infants (Figure 3).
Thus, we suggest that other factors associated with prematurity,
such as the hyperinflammatory response of the immature gastro-
intestinal tract (Nanthakumar et al., 2011), also contribute to the
development of NEC in UPEC-colonized infants.
The association of UPEC lineages with NEC-associated death
is concerning (OR 10.3, p < 0.001) and underscores the impor-
tance of determining the epidemiology of colonization. Colonizing
strainsmaybederived frombothmaternal andenvironmental res-
ervoirs such as the neonatal intensive care unit (Adlerberth and
Wold, 2009; Brooks et al., 2014; Fryklund et al., 1992). However,
both cultivation-based and metagenomic approaches have
shown that no particular strain correlates with NEC (Hoy et al.,
2000; Raveh-Sadka et al., 2015).2920 Cell Reports 14, 2912–2924, March 29, 2016 ª2016 The AuthorOur finding that greatest NEC risk is associated with a subset
of functionally related E. coli strains—specifically, uropatho-
genic E. coli—could be overlooked by analysis of specific strain
types (e.g., based on MLST or genomic SNP variants) or by
considering E. coli as a single taxonomic group or OTU (e.g.,
based on 16S rDNA). Having defined the nature of a risk-asso-
ciated pathogen, we anticipate our finding will assist epidemio-
logical investigation of the sources of UPEC colonization and
NEC risk.
Four preterm twin pairs each harbored the same MLST, sug-
gesting common early colonization. For infants who developed
NEC, we observed a correlation of vaginal delivery with NEC-
associated death (p = 0.018). In these same infants, the carriage
of UPEC in any sample also correlates with vaginal birth (p =
0.057), suggesting that UPEC colonization occurs at birth. If
the primary reservoir for infant colonization by UPEC is the
maternal gut or urinary tract, an opportunity exists for typing
thematernal strain prior to onset of NEC indications. If the strains
are primarily nosocomially acquired, then routine surveillance of
strains present in the care environment should be emphasized.
In either scenario, proactive typing of the colonizing strains
would allow assessment of NEC risk and, importantly, risk of
NEC-associated death before NEC is indicated.
Klebsiella as a Potential NEC Risk Factor
E. coli and Klebsiella spp. exhibited similar carriage frequency
in this study. However, E. coliwas unusual in that, when present,
it was frequently the dominant organism in the community with a
median relative abundance exceeding 80%. In contrast, the next
highest median abundance was 48% for Klebsiella spp. and only
in the days 17–22 collection window. We were not able to assign
a species to the Klebsiella spp., however, preliminary pan-
genomic analysis incorporating K. pneumoniae reference ge-
nomes indicates the majority of the Klebsiella spp. functionally
cluster with K. pneumoniae subspecies (data not shown).
Although Klebsiella spp. prevalence did not significantly corre-
late with NEC, Klebsiella spp. subclades may. Torrazza et al.
(2013) report that an OTUmost similar to K. pneumoniaewas en-
riched in the first stool samples collected after birth and corre-
lated with subsequent development of NEC.
UPEC Antibiotic Resistance May Confound Therapy
Duration of antibiotic treatment has been significantly correlated
with increased risk of NEC and death in preterm infants (Alex-
ander et al., 2011; Cotten et al., 2009; Kuppala et al., 2011).s
Infants with increased antibiotic treatment are likely to have con-
foundingmedical conditions, other than specific bacterial coloni-
zation, that may also increase their risk of developing NEC. Here,
high antibiotic treatment is associated with increased E. coli car-
riage but reduced carriage of Klebsiella spp. This suggests that
Klebsiella may be susceptible to antibiotic treatment and that
E. coli are more likely to be resistant. A striking finding from
our analysis was that NEC infants in whom Klebsiella spp. is de-
tected are likely to survive NEC (p = 0.057). Possibly, differential
resistance characteristics between the two species contribute
to differential outcomes in NEC-associated deaths. Surveys of
antibiotic resistance profiles of UPEC isolates report high levels
of resistance to ampicillin and gentamicin (Banerjee et al., 2013;
Shariff V.A et al., 2013; Wang et al., 2014), a combination
frequently used to treat NEC and the combination used in this
study. Depending on the colonizing strain, this combination of
antibiotics may be less effective for preventing or treating
UPEC-associated NEC. Early identification of colonizing sub-
types and, ideally, their antibiotic resistance profiles, could
inform lifesaving care decisions and the selection of effective
antibiotics.
Dysbiosis and UPEC Establishment
Diversity was lower among infants receiving high antibiotic
administration. Diversity was higher at days 17–22 in preterm
controls but decreased in infants who developed NEC. Because
our measurements are relative abundance, loss of diversity
necessarily correlates with increased relative abundance of
fewer taxa. Here, we observed increased prevalence of E. coli
in infant groups where alpha diversity was decreased. High anti-
biotic administration at days 17–22 was associated with lower
relative abundance of Clostridiales and Veillonella. NEC was
also associated with lower relative abundance of Veillonella.
Clostridiales and Veillonella are relatively enriched in term
infants and do not appear to be significantly influenced by
mode of birth in preterm infants. Either loss of overall diversity
or loss of these key taxa could represent a dysbiosis predispos-
ing infants toward increased abundance of E. coli and increased
NEC risk.
Alternatively, colonization by E. coli, particularly UPEC, may
be an event that promotes dysbiosis and increases the likelihood
of antibiotic administration. When observed, E. coli frequently
dominated the community. The relative dominance of E. coli
may drive the decreased diversity rather than decreased diver-
sity preceding increased E. coli abundance. Either way, high
antibiotic exposure may favor UPEC strains and reduce the rela-
tive abundance and diversity of antibiotic sensitive taxa.
Alternative Etiologies of NEC
Although we identified UPEC to be the major risk factor for NEC,
we also observed NEC cases where Klebsiella was dominant. In
a recent study, applying both culture-based and qPCR assays,
Cassir et al. (2015) found NEC to be significantly associated
with the presence of cytotoxic C. butyricum strains, reporting
that, of 15 NEC cases from 4 different neonatal intensive care
units, all carriedC. butyricum. Metagenomic analysis in our study
detected C. butyricum in only 1 of 27 preterm infants who devel-
oped NEC (3.7%) and in 22 of 117 (18.8%) preterm infants whoCelldid not develop NEC. Detection methods differed between the
two studies and our study did not utilize an assay specific for
C. butyricum. Additionally, Cassir et al. (2015) analyzed samples
obtained at the time of NEC diagnosis, whereas our sampling
was limited to the first weeks of life. Although our study does
not implicateC. butyricum, it is consistent with the idea that there
may be multiple etiologies of NEC.
Conclusions
The epidemiology, and rapid identification, of E. coli strains may
be critical to understanding NEC pathology. We demonstrate
that metagenomic sequencing in combination with computa-
tional approaches for strain-level, functional profiling is an effec-
tive, cultivation-free approach for investigating the epidemiology
of colonizing E. coli. We have shown that detection of UPEC
strains indicates risk of NEC and death as an outcome in preterm
infants. Future studies should attempt to identify the character-
istics of potentially beneficial perinatal antibiotic administration
to the mother. Furthermore, proactive typing of the colonizing
strains should allow assessment of infants at heightened risk
for developing NEC and potentially inform selection of antibiotic
therapies to improve outcomes.
EXPERIMENTAL PROCEDURES
Subjects
Preterm study infants were enrolled from two level III neonatal intensive care
units (NICUs) in Cincinnati, OH, fromDecember 2009 to July 2012, andone level
III NICU in Birmingham, AL, from June 2010 to December 2011, as part of a
cohort study of novel biomarkers for NEC. The Cincinnati Children’s Hospital
Medical Center Institutional Review Board, the University of Alabama Institu-
tional ReviewBoard, the TriHealth Institutional ReviewBoard, and theUniversity
of Cincinnati Institutional Review Board approved this study. Written consent
was obtained from parents or guardians of study subjects. NEC was defined
as Bell’s Stage II or III. Infants with congenital anomalies or spontaneous intes-
tinal perforationwere excluded from the study. Data collection used a standard-
ized protocol describedpreviously (Morrowet al., 2013). All NECcases less than
30 weeks GA were identified, and 4 matched controls were identified per case.
NEC incidence by GA of 23–29 weeks was 0.5, 0.21, 0.21, 0.15, 0.21, and 0.11,
respectively. NEC incidence and UPEC detection did not significantly differ by
birth year, hospital, or NICU (Table S4). Seven NEC cases were enrolled but
not included in the study because they either failed to stool prior to NEC or the
stool prior to NEC failed to yield sufficient DNA for shotgun sequencing; two of
these seven NEC cases died. NEC mortality in this study was 15/27 (55.6%,
95% CI, 36.9%–74.3%). Because NEC-associated mortality typically ranges
from 20%–40%, we examined the possibility that mortality was significantly
higher than expected. Based on the birth weight distribution of our cases, and
applying the birth-weight-specific mortality rates for NEC reported by Fitzgib-
bons et al. (2009), we calculated the expected mortality of our NEC cases to
be 37.0%, which is within the CI of our observed rate. Thus, although the re-
ported mortality is high, it is not evidently higher than expected given the birth
weight rangeof ourcases. Themedianquantity of humanmilkgivenover thefirst
28 days of life was 85% of total enteral feedings. All but three infants received
eithermother’s ownmilk, pasteurized human donormilk, or both. Perinatal anti-
biotic administration is defined as maternal antibiotic use during the admission
and prior to delivery of the study infant(s).
Stool Extraction
Thawed stool was pelleted and resuspended in TE buffer with lysozyme and
proteinase K at 0.24 g stool per 100 ul Buffer RLT (QIAGEN) with beta-mercap-
toethanol. Samples were homogenized for 3 min in a bead beater with 0.3 g of
0.1 mm glass beads and debris pelleted. DNA was isolated with the QIAGEN
AllPrep DNA/RNA Mini Kit (QIAGEN).Reports 14, 2912–2924, March 29, 2016 ª2016 The Authors 2921
Sequencing Data and Availability
A minimal read length filter of 80 nt was applied to all data used in analysis.
Human sequences were removed from the dataset prior to analysis and sub-
mission by alignment to the human genome (Genome Reference Consortium
Human Build 37 patch release 5; http://www.ncbi.nlm.nih.gov/assembly/
GCF_000001405.17/) using theBurrows-Wheeler Aligner (Li andDurbin, 2009).
Sample Selection
Samples were collected at days 3–22 of life. This dataset represents 405 sam-
ples from 166 infants, 22 of whom were term (Figure S2). 27 preterm infants
developed NEC (median day of NEC onset = 21, range = 7,39). During the
study, the initial method of sample extraction was supplanted by a second
method that was then applied to the majority of collected samples (Morrow
et al., 2013). To avoid potentially confounding influences of extraction proto-
col, all community-oriented analyses (Table 1; Figures 1, 2, and S3–S6) were
performed on infants whose samples were extracted by the second protocol
(77% of all infants in study; 105 preterm infants, and all 22 term infants). Ana-
lyses of E.coli gene content and strain subtypes (Figures 3 and S7; Tables 2–4),
and of association of UPECwith NEC and death (Table 4), included all infants in
the study.
Community Analysis
Ifmultiple samples from the same infantwere availablewithin ananalysiswindow
(3–9, 10–16, or 17–22 days), then the sample of latest postnatal collection day
was selected. Selection resulted in 262 samples from 127 infants; 16 of the 105
preterm infants developed NEC (median day of NEC onset = 26, range = 10,39).
E.coli Gene Content and MLST Analysis
We identified 130 samples from 58 infants with reads mapping to E. coli ge-
nomes (Figure S2); all were subjected to gene content and MLST analysis.
When multiple E. coli containing samples were available from a single infant,
the sample with the highest E. coli relative abundance, and >10%, was
selected (mean = 79.9%, SD = 26.7) for clade construction and gene-associ-
ation analysis (Figure 3; Tables 2 and 3). For OR calculation of UPEC as a risk
factor for NEC, NEC-associated deaths, and all deaths, all 143 preterm infants
were considered (Table 4; Figure S2).
Community Profiling
Relative taxonomic abundances were determined with MetaPhlAn version 2.0
(Segata et al., 2012; Truong et al., 2015). Resulting species-level abundance
estimates were considered for all analysis. Heatmaps were generated with
hclust2 (https://bitbucket.org/nsegata/hclust2) using Bray-Curtis dissimilarity
for sample clustering. QIIME (Caporaso et al., 2010) package scripts were
used to estimate alpha diversity.
Pangenome-Based Strain-Level Profiling of E.coli from
Metagenomes
We generated the E.coli pangenome from 116 sequenced reference genomes
(Table S3) selected to maximize diversity using PhyloPhlAn (Segata et al.,
2013). Genes were clustered into gene families based on 95% sequence sim-
ilarity using USEARCH (Edgar, 2010), yielding a set of 21,351 gene families es-
tablishing the pangenome. Sequences were mapped to all 116 representative
E.coli genomes with Bowtie2 (version 2.1.0; very-sensitive option). The cover-
ages of all gene locations were extracted with Samtools (Li et al., 2009) and
merged as gene-family coverage profiles. A uniform and consistent coverage
depth across an expected genome gene set of about 4,600 gene families was
used to define the presence of an E.coli strain in a sample. Based on a cutoff of
half the median depth, coverage levels were converted into gene-family pres-
ence and absence profiles that represent the individual gene set of a specific
strain captured in a sample. Thesemethods have been implemented as part of
the PanPhlAn tool (Scholz et al., 2016) available at http://segatalab.cibio.unitn.
it/tools/panphlan.
To functionally sub-type E. coli strains present in the metagenomes, gene-
family presence and absence profiles were hierarchically clustered withWard’s
minimum variancemethod implemented in the R package, pvclust (http://www.
sigmath.es.osaka-u.ac.jp/shimo-lab/prog/pvclust/). Multiscale bootstrap re-
samplingwasperformedwith10,000 iterationsand theApproximatelyUnbiased
p value (Shimodaira, 2004) is reported. The resulting dendrogramwas rendered
using FigTree software (http://tree.bio.ed.ac.uk/software/figtree/).2922 Cell Reports 14, 2912–2924, March 29, 2016 ª2016 The AuthorMetagenomic MLST Analysis
We developed a metagenomic approach to exploit the MLST strategy
commonly used in cultivation-based typing assays (Maiden et al., 1998).
Reads were mapped with Bowtie2 against a database of the known E. coli
MLST sequences corresponding to distinct alleles of seven genes: adk,
fumC, gyrB, icd, mdh, purA, and recA (parameters -D 20 -R 3 -N 0 -L 20 -i
S,1,0.50). A consensus sequence for each loci was constructed considering
the nucleotide with the highest frequency in each position. All samples where
all loci obtained a minimum breath of coverage of at least 90% were confi-
dently mapped. For the small fraction of loci with low or non-complete
coverage (2.11% of the loci in the positive samples), the best-matching refer-
ence allele from the MLST database was used to fill the uncovered positions.
Reconstructed consensus alleles were used to determine the most abundant
MLST (ST) profile in a sample based on known E. coli ST profiles—3,895
known profiles from the University of Warwick Medical School MLST data-
base, http://mlst.warwick.ac.uk/mlst/ (Wirth et al., 2006).
Statistical Methods
Significance assessment with LEfSe (Segata et al., 2011) first applies the non-
parametric factorial Kruskal-Wallis sum-rank test to detect taxa with signifi-
cant differential abundance with respect to the subject class of interest. LEfSe
then uses linear discriminant analysis (LDA) to estimate the effect size of each
differentially abundant feature. The alpha value applied for factorial Kruskal-
Wallis testing was 0.05; the threshold applied on the logarithmic LDA score
for feature discrimination was 2.0. Significance in class comparisons of alpha
diversity was calculated with a non-parametric, two-sample t test with 10,000
Monte Carlo simulations implemented in the Qiime 1.8.0 script compare_al-
pha_diveristy.py. All other p values reported throughout the manuscript were
calculated as two-tailed Fisher’s exact probability test for 2 3 2 contingency
tables unless otherwise specified.
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